Zhao RS - Search Results

1

Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Mease PJ, Ogdie A, Tesser J, Shiff NJ, Zhao RS, Chakravarty SD, Kelleman M, Dodge R, McLean RR, Broadwell A, Kavanaugh A, Merola JF. Mease PJ, et al. Among authors: zhao rs. ACR Open Rheumatol. 2024 May;6(5):304-311. doi: 10.1002/acr2.11657. Epub 2024 Feb 28. ACR Open Rheumatol. 2024. PMID: 38417434 Free PMC article.

2

Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.

Walsh JA, Lin I, Zhao R, Shiff NJ, Morrison L, Emond B, Yu LH, Schwartzbein S, Lefebvre P, Pilon D, Chakravarty SD, Mease P. Walsh JA, et al. Drugs Real World Outcomes. 2024 Sep;11(3):487-499. doi: 10.1007/s40801-024-00428-z. Epub 2024 Jul 31. Drugs Real World Outcomes. 2024. PMID: 39083163 Free PMC article.

3

Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis.

Zhdanava M, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, Pilon D. Zhdanava M, et al. Patient Prefer Adherence. 2024 Apr 10;18:809-820. doi: 10.2147/PPA.S446861. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38617809 Free PMC article.

4

Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States.

Zhdanava M, Zhao R, Manceur AM, Kachroo S, Lefebvre P, Pilon D. Zhdanava M, et al. Crohns Colitis 360. 2023 Sep 4;5(3):otad045. doi: 10.1093/crocol/otad045. eCollection 2023 Jul. Crohns Colitis 360. 2023. PMID: 37671391 Free PMC article.

5

Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up.

Zhao R, Ding Z, Gupta P, Gozalo L, Bruette R, Johnson VM, Maughn K, Liu Y, Kachroo S. Zhao R, et al. J Health Econ Outcomes Res. 2023 Nov 20;10(2):111-120. doi: 10.36469/001c.88947. eCollection 2023. J Health Econ Outcomes Res. 2023. PMID: 38025989 Free PMC article.

6

Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States.

Zhdanava M, Zhao R, Manceur AM, Ding Z, Boudreau J, Kachroo S, Kerner C, Izanec J, Pilon D. Zhdanava M, et al. J Manag Care Spec Pharm. 2024 Feb 3;30(2):141-152. doi: 10.18553/jmcp.2024.30.2.141. J Manag Care Spec Pharm. 2024. PMID: 38308626 Free PMC article.

7

Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumab.

Zhdanava M, Zhao R, Manceur AM, Ding Z, Kachroo S, Holiday C, Lefebvre P, Pilon D. Zhdanava M, et al. J Manag Care Spec Pharm. 2023 Aug;29(8):907-916. doi: 10.18553/jmcp.2023.29.8.907. J Manag Care Spec Pharm. 2023. PMID: 37523319 Free PMC article.

8

Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumab.

Zhdanava M, Ding Z, Manceur AM, Zhao R, Holiday C, Kachroo S, Izanec J, Pilon D. Zhdanava M, et al. Curr Med Res Opin. 2023 Sep;39(9):1215-1225. doi: 10.1080/03007995.2023.2246882. Epub 2023 Aug 26. Curr Med Res Opin. 2023. PMID: 37563994

9

Persistence Among Patients with Crohn Disease Previously Treated with an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent.

Zhdanava M, Kachroo S, Manceur AM, Ding Z, Holiday C, Zhao R, Godwin B, Pilon D. Zhdanava M, et al. Clin Ther. 2023 Aug;45(8):770-777. doi: 10.1016/j.clinthera.2023.06.013. Epub 2023 Jul 11. Clin Ther. 2023. PMID: 37442653

10

Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States.

Mody R, Huang Q, Yu M, Zhao R, Patel H, Grabner M, Landó LF. Mody R, et al. Diabetes Obes Metab. 2019 Apr;21(4):920-929. doi: 10.1111/dom.13603. Epub 2019 Jan 9. Diabetes Obes Metab. 2019. PMID: 30520248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters